mGluR5-PLCbeta4-PKCbeta2/PKCgamma pathways in hippocampal CA1 pyramidal neurons in pilocarpine model of status epilepticus in mGluR5+/+ mice

Epilepsy Res. 2008 Dec;82(2-3):111-23. doi: 10.1016/j.eplepsyres.2008.07.014. Epub 2008 Sep 5.

Abstract

While it is generally accepted that phospholipase C (PLC) and protein kinase C (PKC) are down-stream proteins involved in metabotropic glutamate receptor 5 (mGluR5)-related signal transduction, we still do not know which subtype of PLC or PKC is specifically regulated after mGluR5 activation. In the present study in mGluR5 wild-type (mGluR5+/+) mice, we showed induced PKCbeta2 or PKCgamma expression at the border between the stratum oriens and alveus (O/A border) at 2h during pilocarpine induced status epilepticus (SE), and in the stratum pyramidale in CA1 area at 1 day after pilocarpine induced SE; at 1 day, induced expression of PLCbeta4 in the stratum pyramidale of CA1 area was observed. Furthermore, double labeling revealed the co-localization of induced PKCbeta2 or PKCgamma with mGluR5 or with induced PLCbeta4 in the stratum pyramidale of CA1 area. These induced expression, however, were not found in mGluR5 mutant (mGluR5-/-) mice. It suggests that induced PLCbeta4-PKCbeta2/PKCgamma at 1 day after pilocarpine induced SE in pyramidal neurons or PKCbeta2 or PKCgamma in interneurons at O/A border at 2h during pilocarpine induced SE may be specifically linked to the activation of mGluR5. When compared to mGluR5+/+ mice, significant shorter latency (from pilocarpine injection to the occurrence of status epilepticus) and maintenance period (from beginning to the end of status epilepticus) for status epilepticus in mGluR5-/- mice were also demonstrated. It is possible that mGluR5 may play a negative role in initiation of status epilepticus by interacting with muscarinic acetylcholine receptor in mGluR5+/+ mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Progression
  • Female
  • Gene Deletion
  • Hippocampus / drug effects
  • Hippocampus / metabolism*
  • Hippocampus / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Muscarinic Agonists / administration & dosage
  • Muscarinic Agonists / toxicity
  • Nerve Degeneration / etiology
  • Nerve Degeneration / metabolism
  • Nerve Degeneration / pathology
  • Nerve Tissue Proteins / biosynthesis*
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / physiology
  • Phospholipase C beta / biosynthesis*
  • Phospholipase C beta / genetics
  • Phospholipase C beta / physiology
  • Pilocarpine / administration & dosage
  • Pilocarpine / toxicity
  • Protein Kinase C / biosynthesis*
  • Protein Kinase C / genetics
  • Protein Kinase C / physiology
  • Protein Kinase C beta
  • Pyramidal Cells / metabolism*
  • Receptor, Metabotropic Glutamate 5
  • Receptors, Metabotropic Glutamate / genetics
  • Receptors, Metabotropic Glutamate / physiology*
  • Receptors, Muscarinic / physiology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Status Epilepticus / chemically induced
  • Status Epilepticus / metabolism*
  • Time Factors

Substances

  • Grm5 protein, mouse
  • Muscarinic Agonists
  • Nerve Tissue Proteins
  • Receptor, Metabotropic Glutamate 5
  • Receptors, Metabotropic Glutamate
  • Receptors, Muscarinic
  • Pilocarpine
  • protein kinase C gamma
  • protein kinase C zeta
  • Protein Kinase C
  • Protein Kinase C beta
  • Phospholipase C beta
  • Plcb4 protein, mouse